Suppr超能文献

降钙素原、C 反应蛋白和中性粒细胞与淋巴细胞比值与中国住院 COVID-19 患者死亡率的关系。

Associations of procalcitonin, C-reaction protein and neutrophil-to-lymphocyte ratio with mortality in hospitalized COVID-19 patients in China.

机构信息

Department of Critical Care Medicine, School of Clinical Medicine, Jiamusi University, No. 348, Dexiang Street, Jiamusi, 154000, Heilongjiang Province, China.

Department of Neurology and Respirator Intensive Care Unit, Heilongjiang Provincial Hospital, No. 82, Zhongshan Road, Harbin, 150036, Heilongjiang Province, China.

出版信息

Sci Rep. 2020 Sep 14;10(1):15058. doi: 10.1038/s41598-020-72164-7.

Abstract

Coronavirus disease 2019 (COVID-19) is an important and urgent threat to global health. Inflammation factors are important for COVID-19 mortality, and we aim to explore whether the baseline levels of procalcitonin (PCT), C-reaction protein (CRP) and neutrophil-to-lymphocyte ratio (NLR) are associated with an increased risk of mortality in patients with COVID-19. A retrospective study was conducted and a total of 76 patients with confirmed COVID-19 were included between January 17, 2020 to March 2, 2020, of these cases, 17 patients were dead. After adjusting covariates, PCT (≥ 0.10 ng/mL) and CRP (≥ 52.14 mg/L) exhibited independent increasing risks of mortality were used hazard ratio (HR) of 52.68 (95% confidence interval [CI]: 1.77-1571.66) and 5.47 (95% CI: 1.04-28.72), respectively. However, NRL (≥ 3.59) was not found to be an independent risk factor for death in our study. Furthermore, the elevated PCT levels were still associated with increasing risk of mortality in the old age group (age ≥ 60 y), and in the critically severe and severe patients after adjustment for complications. Thu Baseline levels of PCT and CRP have been addressed as independent predictors of mortality in patients with COVID-19.

摘要

2019 年冠状病毒病(COVID-19)是对全球健康的一个重要且紧迫的威胁。炎症因子对 COVID-19 的死亡率很重要,我们旨在探讨降钙素原(PCT)、C 反应蛋白(CRP)和中性粒细胞与淋巴细胞比值(NLR)的基线水平是否与 COVID-19 患者的死亡风险增加相关。进行了一项回顾性研究,共纳入 2020 年 1 月 17 日至 2020 年 3 月 2 日期间确诊的 76 例 COVID-19 患者,其中 17 例死亡。在调整协变量后,PCT(≥0.10ng/mL)和 CRP(≥52.14mg/L)独立显示出增加死亡风险的作用,危险比(HR)分别为 52.68(95%置信区间[CI]:1.77-1571.66)和 5.47(95% CI:1.04-28.72)。然而,NLR(≥3.59)在本研究中并不是死亡的独立危险因素。此外,在调整并发症后,高龄组(年龄≥60 岁)和危重症及重症患者中,升高的 PCT 水平仍与死亡率增加相关。因此,PCT 和 CRP 的基线水平被认为是 COVID-19 患者死亡率的独立预测因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7477/7490259/d3559f6b5397/41598_2020_72164_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验